Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

TIANDA PHARMA (0455.HK)

Compare
0.168
-0.012
(-6.67%)
At close: April 2 at 1:04:12 PM GMT+8
Loading Chart for 0455.HK
  • Previous Close 0.180
  • Open 0.162
  • Bid 0.156 x --
  • Ask 0.172 x --
  • Day's Range 0.162 - 0.169
  • 52 Week Range 0.155 - 0.275
  • Volume 178,000
  • Avg. Volume 33,360
  • Market Cap (intraday) 361.207M
  • Beta (5Y Monthly) -0.13
  • PE Ratio (TTM) --
  • EPS (TTM) -0.020
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield 0.00 (1.55%)
  • Ex-Dividend Date Jun 13, 2024
  • 1y Target Est --

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It provides Chinese medicines, chemical drugs, biological and health products, and medical appliances covering therapy areas of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, anti-cancer, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces, and Chinese medicines; provision of Chinese medicine clinical and medical services; and trading of agricultural by-products. In addition, the company provides healthcare services, such as general TCM treatment, health preservation, and health management services, as well as personalized systems for disease diagnosis, treatment, and prevention along with health preservation. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

www.tiandapharma.com

701

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0455.HK

View More

Performance Overview: 0455.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0455.HK
0.59%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

0455.HK
33.39%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

0455.HK
24.76%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

0455.HK
18.23%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 0455.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0455.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    361.21M

  • Enterprise Value

    362.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.94

  • Price/Book (mrq)

    0.66

  • Enterprise Value/Revenue

    0.94

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.60%

  • Return on Assets (ttm)

    -4.02%

  • Return on Equity (ttm)

    -11.19%

  • Revenue (ttm)

    329.94M

  • Net Income Avi to Common (ttm)

    -61.37M

  • Diluted EPS (ttm)

    -0.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    85.69M

  • Total Debt/Equity (mrq)

    25.20%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0455.HK

View More

Company Insights: 0455.HK

Research Reports: 0455.HK

View More

People Also Watch